276
Views
29
CrossRef citations to date
0
Altmetric
Short Communication

Future Prospects: Assessment of Intraoperative Optical Coherence Tomography in Ab Interno Glaucoma Surgery

, , , , , & show all
Pages 1288-1291 | Received 19 Sep 2014, Accepted 29 Nov 2014, Published online: 30 Dec 2014
 

Abstract

Purpose: Ab interno glaucoma surgery, such as trabecular aspiration or ab interno trabeculotomy, has been introduced as an alternative, non-filtering procedure to lower intraocular pressure in glaucoma patients. The purpose of the present study was to assess the feasibility of intraoperative spectral domain optical coherence tomography (iOCT) for improving ab interno glaucoma surgery.

Materials and Methods: Intraoperative optical coherence tomography was performed to visualize the anterior chamber angle, the aspiration canula during trabecular aspiration, and the trabectome device during ab interno trabeculotomy. A commercially available 840-nm iOCT was used in a clinical setting, a 1310-nm spectral-domain OCT in an experimental setting.

Results: In the clinical setting using the 840-nm iOCT, visualization of the aspiration canula and the trabectome device was possible, however, with rather limited visibility of the chamber angle and the trabecular meshwork. In the experimental setting, the 1310-nm OCT enabled excellent visualization of the chamber angle and detailed evaluation of the instrument–trabecular meshwork relation.

Conclusions: Intraoperative use of optical coherence tomography may be helpful for ab interno glaucoma surgery. Adjustments of the commercially available iOCT, including longer wavelengths and oblique scanning options, are necessary for the clinical use.

Acknowledgments

Sigrid Roters, MD, Department of Ophthalmology, University of Cologne, provided expert surgical support; and Martin Hagen-Eggert, Institute of Biomedical Optics, University of Luebeck, provided excellent technical advice.

Declaration of interest

L. M. H, S. S., T. D., G. H., C. C., and P.S. have no financial or proprietary interest in any material or method mentioned in the manuscript. Eva Lankenau is an employee and shareholder of OptoMedical Technologies GmbH, Luebeck, Germany.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.